Project description
Computer-aided enzyme design and production
Enzymes are nature's little chemists. They have the power to speed up biochemical reactions without generating waste byproducts or consuming excessive energy. That's why they are used in industrial processes like production of cosmetics and pharmaceuticals. By using the right tools, enzymes can also be engineered to fit specific processes that still rely on polluting chemical catalysis. The EU-funded ZYMEVOLVER project has developed a computational tool to better perform enzyme engineering. The goal is to develop new industrial enzymes with very high accuracy in substrate selectivity and operation. Introduction of the in silico tool into the market will bring significant savings for companies looking to innovate and contribute to a more sustainable industry.
Objective
Actually, global enzymes market is today €8.18 billion and forecasted to reach €17.5 billion by 2024, so a sector growing at a CARG +9.56% in a 7-year projection. Europe is a main contender with over 62% of the exports. However, most companies with dedicated software for protein engineering computational are found in North America (46.0%), followed by Europe (29.4%), Asia-Pacific (17.9%) and RoW (6.7%).
The production of daily life products such as paper, textiles, food, feed, chemicals and pharmaceuticals consumes large amounts of resources, water and energy. Furthermore, it generates enormous amounts of waste with an adverse impact on our environment and quality of life. Many studies show that implementing enzymatic processes instead of conventional chemical catalysis contributes to a more sustainable industry, reducing global warming (OECD, 2009; European Commission, 2009).
ZYMVOLVER is a computer-driven speciality management to protein producers and industrial manufacturers. It offers a computer-aided decision-making tool for the adoption of industrial enzymes in standard industrial processes. We have developed a tool that will allow the democratization of computer-aided protein engineering. We offer a state-of-the-art, accessible, all-in-one computational tool that customize proteins with a 90% accuracy in terms of substrate selectivity, far beyond competition.
ZYMEVOLVER - is exclusively owned by Zymvol. Our cloud-based, cost-effective software allows us to design any industrial enzyme from scratch, saving 50% of time and enzyme developing costs.
The founding of Zymvol Biomodeling SL has over 20 years of combined experience previously working at one of Europe’s most important supercomputers – Barcelona Supercomputing Centre, which has been a necessary infrastructure for protein editing.
ZYMVOL won the first prize in the pitch competition for most promising industrial start-up of 2017 organized by IQS Tech Factory and Richi Social Entrepreneurs in Boston.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- engineering and technologyother engineering and technologiesfood technology
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringcomputer hardwaresupercomputers
- natural scienceschemical sciencescatalysisbiocatalysis
- engineering and technologyindustrial biotechnologybiomaterialsbiofuels
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsenzymes
You need to log in or register to use this function
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
08018 Barcelona
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.